Antisense oligonucleotides for therapeutic intervention

[1]  B. Calabretta,et al.  Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides. , 1991, Science.

[2]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[3]  Gwyn T. Williams.  Programmed cell death: Apoptosis and oncogenesis , 1991, Cell.

[4]  S. Swerdlow,et al.  A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis , 1991, Cell.

[5]  C. Sartorius,et al.  Hybridization arrest of cell-free translation of the malarial dihydrofolate reductase/thymidylate synthase mRNA by anti-sense oligodeoxyribonucleotides. , 1991, Nucleic acids research.

[6]  J. Roth,et al.  Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA. , 1991, Cancer research.

[7]  B. Calabretta,et al.  Normal and leukemic hematopoietic cells manifest differential sensitivity to inhibitory effects of c-myb antisense oligodeoxynucleotides: an in vitro study relevant to bone marrow purging. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  G. Tortora,et al.  Differentiation of HL-60 leukemia by type I regulatory subunit antisense oligodeoxynucleotide of cAMP-dependent protein kinase. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[9]  B. Lebleu,et al.  Antiproliferative effects of antisense oligonucleotides directed to the RNA of c-myc oncogene. , 1991, Nucleic acids research.

[10]  R. Morrison.  Suppression of basic fibroblast growth factor expression by antisense oligodeoxynucleotides inhibits the growth of transformed human astrocytes. , 1991, The Journal of biological chemistry.

[11]  J. Laurence,et al.  Induction of chronic human immunodeficiency virus infection is blocked in vitro by a methylphosphonate oligodeoxynucleoside targeted to a U3 enhancer element , 1991, Journal of virology.

[12]  E. Wickstrom,et al.  Walking along human c-myc mRNA with antisense oligodeoxynucleotides: maximum efficacy at the 5' cap region. , 1991, Oncogene research.

[13]  G. Tortora,et al.  Suppression of malignancy targeting the intracellular signal transducing proteins of cAMP: the use of site-selective cAMP analogs, antisense strategy, and gene transfer. , 1991, Life sciences.

[14]  R. Erickson,et al.  Antisense inhibition of beta-glucuronidase expression in preimplantation mouse embryos: a comparison of transgenes and oligodeoxynucleotides. , 1991, Antisense research and development.

[15]  L. Sheffield.  Oligonucleotides antisense to catalytic subunit of cyclic AMP-dependent protein kinase inhibit mouse mammary epithelial cell DNA synthesis. , 1991, Experimental cell research.

[16]  S. L. Berger,et al.  Prothymosin alpha antisense oligomers inhibit myeloma cell division. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Szoka,et al.  Rapid nuclear accumulation of injected oligodeoxyribonucleotides. , 1990, The New biologist.

[18]  T. Lee,et al.  Expression of chimeric tRNA-driven antisense transcripts renders NIH 3T3 cells highly resistant to Moloney murine leukemia virus replication , 1990, Molecular and cellular biology.

[19]  R. Schultz,et al.  Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes. , 1990, Cancer research.

[20]  K. Watabe,et al.  Antisense oligodeoxyribonucleotides inhibit the expression of the gene for hepatitis B virus surface antigen. , 1990, The Journal of general virology.

[21]  Y. Cheng,et al.  Mechanisms of inhibition of herpes simplex virus type 2 growth by 28-mer phosphorothioate oligodeoxycytidine. , 1990, The Journal of biological chemistry.

[22]  G. Nabel,et al.  Regulation of gene expression with double-stranded phosphorothioate oligonucleotides. , 1990, Science.

[23]  F. Ruscetti,et al.  Inhibition of murine monocyte proliferation by a colony-stimulating factor-1 antisense oligodeoxynucleotide. Evidence for autocrine regulation. , 1990, Journal of immunology.

[24]  B. Calabretta,et al.  Down-regulated c-myb expression inhibits DNA synthesis of T-leukemia cells in most patients. , 1990, Cancer research.

[25]  Y. Cho‐Chung.  Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. , 1990, Cancer research.

[26]  J. Toulmé,et al.  Blockage of AM V reverse transcriptase by antisense oligodeoxynucleotides , 1990, FEBS letters.

[27]  Eli Gilboa,et al.  Overexpression of TAR sequences renders cells resistant to human immunodeficiency virus replication , 1990, Cell.

[28]  J C Reed,et al.  Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides. , 1990, Cancer research.

[29]  H. Buck,et al.  Inhibition of HIV-1 infectivity by phosphate-methylated DNA: retraction. , 1990, Science.

[30]  L. Neckers,et al.  Antisense inhibition of single copy N-myc expression results in decreased cell growth without reduction of c-myc protein in a neuroepithelioma cell line. , 1990, Cancer research.

[31]  L. Leserman,et al.  Inhibition of expression of human immunodeficiency virus-1 in vitro by antibody-targeted liposomes containing antisense RNA to the env region. , 1990, The Journal of biological chemistry.

[32]  A. Rhodes,et al.  Inhibition of human immunodeficiency virus replication in cell culture by endogenously synthesized antisense RNA. , 1990, The Journal of general virology.

[33]  J. Toulmé,et al.  Effect of RNA secondary structure and modified bases on the inhibition of trypanosomatid protein synthesis in cell free extracts by antisense oligodeoxynucleotides. , 1990, Nucleic acids research.

[34]  B. Calabretta,et al.  Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[35]  James C. Marsters,et al.  Synthesis, hybridization properties and antiviral activity of lipid- oligodeoxynucleotide conjugates , 1990, Nucleic Acids Res..

[36]  J. Toulmé,et al.  Specific regulation of gene expression by antisense, sense and antigene nucleic acids. , 1990, Biochimica et biophysica acta.

[37]  Y. Cheng,et al.  Inhibition of herpes simplex virus type 2 growth by phosphorothioate oligodeoxynucleotides , 1990, Antimicrobial Agents and Chemotherapy.

[38]  P. Nowell,et al.  BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[39]  H. Buck,et al.  Phosphate-methylated DNA aimed at HIV-1 RNA loops and integrated DNA inhibits viral infectivity. , 1990, Science.

[40]  B. Shiramizu,et al.  Tumour-specific inhibition of lymphoma growth by an antisense oligodeoxynucleotide , 1990, The Lancet.

[41]  J. Rossi,et al.  Ribozymes as potential anti-HIV-1 therapeutic agents. , 1990, Science.

[42]  C. Boiziau,et al.  Les oligonucléotides antisens : outils de génétique moléculaire et agents thérapeutiques , 1990 .

[43]  E. Wickstrom,et al.  Target dependence of antisense oligodeoxynucleotide inhibition of c-Ha-ras p21 expression and focus formation in T24-transformed NIH3T3 cells. , 1990, Oncogene research.

[44]  G. Tortora,et al.  An antisense oligodeoxynucleotide targeted against the type II beta regulatory subunit mRNA of protein kinase inhibits cAMP-induced differentiation in HL-60 leukemia cells without affecting phorbol ester effects. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. V. Vinogradov,et al.  A new class of antivirals: antisense oligonucleotides combined with a hydrophobic substituent effectively inhibit influenza virus reproduction and synthesis of virus‐specific proteins in MDCK cells , 1990, FEBS letters.

[46]  M. Kirschner,et al.  An antisense mRNA directs the covalent modification of the transcript encoding fibroblast growth factor in Xenopus oocytes , 1989, Cell.

[47]  W. Knöchel,et al.  An antisense transcript from the Xenopus laevis bFGF gene coding for an evolutionarily conserved 24 kd protein. , 1989, The EMBO journal.

[48]  B. Rayner,et al.  α-DNA IX: parallel annealing of α-anomeric oligodeoxyribonucleotides to natural mRNA is required for interference in RNase H mediated hydrolysis and reverse transcription , 1989 .

[49]  S. Broder,et al.  Stepwise mechanism of HIV reverse transcriptase: primer function of phosphorothioate oligodeoxynucleotide. , 1989, Biochemistry.

[50]  E. Gilboa,et al.  Inhibition of human T-cell leukemia virus type I replication in primary human T cells that express antisense RNA , 1989, Journal of virology.

[51]  R. Simons,et al.  Naturally occurring antisense RNA control--a brief review. , 1988, Gene.

[52]  M. Reitz,et al.  Phosphorothioate analogs of oligodeoxynucleotides: inhibitors of replication and cytopathic effects of human immunodeficiency virus. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Toulmé,et al.  An acridine-linked oligodeoxynucleotide targeted to the common 5' end of trypanosome mRNAs kills cultured parasites. , 1987, Gene.

[54]  H. Weintraub,et al.  Inhibition of thymidine kinase gene expression by anti-sense RNA: A molecular approach to genetic analysis , 1984, Cell.

[55]  M. Stephenson,et al.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide. , 1978, Proceedings of the National Academy of Sciences of the United States of America.